{"transactions":[{"id":311746,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Performance Shares","published_at":"2026-03-12T20:24:46.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":17143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board."}],"balance_after":17143,"derivative":{"expiration_date":"2029-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":17143},"source":{"system":"sec-edgar","filing":"0001753055-26-000006","document":"wk-form4_1773347083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000006/wk-form4_1773347083.xml","form_type":"4"}},{"id":311745,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Market Share Units","published_at":"2026-03-12T20:24:46.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":11429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board."}],"balance_after":11429,"derivative":{"expiration_date":"2029-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":11429},"source":{"system":"sec-edgar","filing":"0001753055-26-000006","document":"wk-form4_1773347083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000006/wk-form4_1773347083.xml","form_type":"4"}},{"id":312216,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Restricted Stock Units","published_at":"2026-03-03T21:16:42.000Z","date":"2026-02-27","kind":"exercise","planned":false,"acquired":false,"shares":3286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal installments beginning on March 1, 2025."}],"balance_after":3286,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock, $0.10 par value","underlying_shares":3286},"source":{"system":"sec-edgar","filing":"0001753055-26-000004","document":"wk-form4_1772572587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000004/wk-form4_1772572587.xml","form_type":"4"}},{"id":312215,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-03T21:16:42.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1672,"price":62.37,"value":104282.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of award."}],"balance_after":16672,"source":{"system":"sec-edgar","filing":"0001753055-26-000004","document":"wk-form4_1772572587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000004/wk-form4_1772572587.xml","form_type":"4"}},{"id":312214,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2026-03-03T21:16:42.000Z","date":"2026-02-27","kind":"exercise","planned":false,"acquired":true,"shares":3286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest in three equal installments beginning on March 1, 2025."}],"balance_after":18344,"source":{"system":"sec-edgar","filing":"0001753055-26-000004","document":"wk-form4_1772572587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000004/wk-form4_1772572587.xml","form_type":"4"}},{"id":314538,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Restricted Stock Units","published_at":"2026-02-03T21:39:19.000Z","date":"2026-02-01","kind":"exercise","planned":false,"acquired":false,"shares":10079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest annually in three equal installments beginning on February 1, 2025."}],"balance_after":10079,"derivative":{"expiration_date":"2027-02-01","underlying":"Common Stock, $0.10 par value","underlying_shares":10079},"source":{"system":"sec-edgar","filing":"0001753055-26-000002","document":"wk-form4_1770154756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000002/wk-form4_1770154756.xml","form_type":"4"}},{"id":314537,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2026-02-03T21:39:19.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3810,"price":55.05,"value":209740.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock units."}],"balance_after":15058,"source":{"system":"sec-edgar","filing":"0001753055-26-000002","document":"wk-form4_1770154756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000002/wk-form4_1770154756.xml","form_type":"4"}},{"id":314536,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2026-02-03T21:39:19.000Z","date":"2026-02-01","kind":"exercise","planned":false,"acquired":true,"shares":10079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest annually in three equal installments beginning on February 1, 2025."}],"balance_after":18868,"source":{"system":"sec-edgar","filing":"0001753055-26-000002","document":"wk-form4_1770154756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000175305526000002/wk-form4_1770154756.xml","form_type":"4"}},{"id":979215,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T09:16:59.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2033-12-13","underlying":"Ordinary Shares","underlying_shares":15021},"source":{"system":"sec-edgar","filing":"0001193125-25-308804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308804/ownership.xml","form_type":"4"}},{"id":979214,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T09:16:59.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8462,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":3.35,"expiration_date":"2034-05-29","underlying":"Ordinary Shares","underlying_shares":8462},"source":{"system":"sec-edgar","filing":"0001193125-25-308804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308804/ownership.xml","form_type":"4"}},{"id":979213,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T09:16:59.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Transaction Agreement (the \"Agreement\"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. (\"Sub\"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, pursuant to which Sub acquired all the issued and to be issued share capital of the Issuer (the \"Acquisition\") for a cash purchase price of $2.035 per share (the \"Scheme Consideration\"). The Acquisition was completed as of December 5, 2025 (the \"Effective Time\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":2.56,"expiration_date":"2035-06-10","underlying":"Ordinary Shares","underlying_shares":8637},"source":{"system":"sec-edgar","filing":"0001193125-25-308804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308804/ownership.xml","form_type":"4"}},{"id":1112081,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T08:00:04.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":8637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2025. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer."}],"balance_after":8637,"derivative":{"exercise_price":2.56,"expiration_date":"2035-06-10","underlying":"Ordinary Shares","underlying_shares":8637},"source":{"system":"sec-edgar","filing":"0000950170-25-085817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017025085817/ownership.xml","form_type":"4"}},{"id":322268,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2025-05-13T23:03:35.000Z","date":"2025-05-09","kind":"sale","planned":false,"acquired":false,"shares":97.391,"price":38.01,"value":3701.83191,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Based on recent 401(k) plan statement. Reflects the number of stock fund units instead of the estimated number of shares that were reported on previous Form 4s. The units were sold by the reporting person's spouse and represent the complete disposition of stock fund units held by spouse."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000014272-25-000097","document":"wk-form4_1747177408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000097/wk-form4_1747177408.xml","form_type":"4"}},{"id":324284,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Performance Shares","published_at":"2025-03-13T01:29:50.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":20084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board."}],"balance_after":20084,"derivative":{"expiration_date":"2028-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":20084},"source":{"system":"sec-edgar","filing":"0000014272-25-000062","document":"wk-form4_1741829384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000062/wk-form4_1741829384.xml","form_type":"4"}},{"id":324283,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Market Share Units","published_at":"2025-03-13T01:29:50.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":13389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the\ngreater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated\ndividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the\nmaximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR\npercentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board."}],"balance_after":13389,"derivative":{"expiration_date":"2028-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":13389},"source":{"system":"sec-edgar","filing":"0000014272-25-000062","document":"wk-form4_1741829384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000062/wk-form4_1741829384.xml","form_type":"4"}},{"id":324792,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Restricted Stock Units","published_at":"2025-03-04T22:44:02.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":3286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal installments beginning on March 1, 2025."}],"balance_after":6572,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock, $0.10 par value","underlying_shares":3286},"source":{"system":"sec-edgar","filing":"0000014272-25-000045","document":"wk-form4_1741128234.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000045/wk-form4_1741128234.xml","form_type":"4"}},{"id":324791,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-04T22:44:02.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1630,"price":59.62,"value":97180.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of award."}],"balance_after":8789,"source":{"system":"sec-edgar","filing":"0000014272-25-000045","document":"wk-form4_1741128234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000045/wk-form4_1741128234.xml","form_type":"4"}},{"id":324790,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2025-03-04T22:44:02.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":3286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest in three equal installments beginning on March 1, 2025."}],"balance_after":10419,"source":{"system":"sec-edgar","filing":"0000014272-25-000045","document":"wk-form4_1741128234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000045/wk-form4_1741128234.xml","form_type":"4"}},{"id":326696,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Restricted Stock Units","published_at":"2025-02-05T00:05:24.000Z","date":"2025-02-01","kind":"exercise","planned":false,"acquired":false,"shares":10078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal installments beginning on February 1, 2025."}],"balance_after":20158,"derivative":{"expiration_date":"2027-02-01","underlying":"Common Stock, $0.10 par value","underlying_shares":10078},"source":{"system":"sec-edgar","filing":"0000014272-25-000014","document":"wk-form4_1738713917.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000014/wk-form4_1738713917.xml","form_type":"4"}},{"id":326695,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2025-02-05T00:05:24.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3725,"price":58.95,"value":219588.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of award."}],"balance_after":7133,"source":{"system":"sec-edgar","filing":"0000014272-25-000014","document":"wk-form4_1738713917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000014/wk-form4_1738713917.xml","form_type":"4"}},{"id":326694,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Common Stock, $0.10 par value","published_at":"2025-02-05T00:05:24.000Z","date":"2025-02-01","kind":"exercise","planned":false,"acquired":true,"shares":10078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest in three equal installments beginning on February 1, 2025."}],"balance_after":10858,"source":{"system":"sec-edgar","filing":"0000014272-25-000014","document":"wk-form4_1738713917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000014/wk-form4_1738713917.xml","form_type":"4"}},{"id":1490400,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-05T16:16:53.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":8462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This amendment to Form 4 is being filed solely to correct the price of the derivative security, which was previously reported as being $3.35 due to a scrivener's error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer."}],"balance_after":8462,"derivative":{"exercise_price":3.35,"expiration_date":"2034-05-29","underlying":"Ordinary Shares","underlying_shares":8462},"source":{"system":"sec-edgar","filing":"0000950170-24-069330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024069330/ownership.xml","form_type":"4/A","original_submission_date":"2024-06-03"}},{"id":1495393,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T10:23:33.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":8462,"price":3.35,"value":28347.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer."}],"balance_after":8462,"derivative":{"exercise_price":3.35,"expiration_date":"2034-05-29","underlying":"Ordinary Shares","underlying_shares":8462},"source":{"system":"sec-edgar","filing":"0000950170-24-067715","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024067715/ownership.xml","form_type":"4"}},{"id":337735,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Performance Shares","published_at":"2024-03-12T21:45:05.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":5805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance share converts into one share of common stock upon distribution in the first quarter of 2027."}],"balance_after":5805,"derivative":{"expiration_date":"2027-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":5805},"source":{"system":"sec-edgar","filing":"0000014272-24-000056","document":"wk-form4_1710279895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000056/wk-form4_1710279895.xml","form_type":"4"}},{"id":337734,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Market Share Units","published_at":"2024-03-12T21:45:05.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":3870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":3870,"derivative":{"expiration_date":"2028-03-10","underlying":"Common Stock, $0.10 par value","underlying_shares":3870},"source":{"system":"sec-edgar","filing":"0000014272-24-000056","document":"wk-form4_1710279895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000056/wk-form4_1710279895.xml","form_type":"4"}},{"id":338599,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, RayzeBio Org."}}],"security":"Restricted Stock Units","published_at":"2024-03-04T22:57:57.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":9858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal installments beginning on March 1, 2025."}],"balance_after":9858,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock, $0.10 par value","underlying_shares":9858},"source":{"system":"sec-edgar","filing":"0000014272-24-000050","document":"wk-form4_1709593068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427224000050/wk-form4_1709593068.xml","form_type":"4"}},{"id":1673076,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-01-23T20:37:41.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":45.66,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":43328},"source":{"system":"sec-edgar","filing":"0001140361-24-003531","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000114036124003531/form4.xml","form_type":"4"}},{"id":1673075,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-01-23T20:37:41.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":45.66,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":2128},"source":{"system":"sec-edgar","filing":"0001140361-24-003531","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000114036124003531/form4.xml","form_type":"4"}},{"id":1673074,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-23T20:37:41.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement and the Company Equity Plans (as such term is defined in the Merger Agreement), at the Effective Time, each of these RSUs that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash award of BMS in an amount equal to the product of the number of restricted stock units subject to such RSU immediately prior to the Effective Time and the last trading price of a share of Company Common Stock before the Effective Time (the \"Converted Cash Award\"). Following the Effective Time, the Converted Cash Award will be subject to the same terms and conditions applicable to such Issuer RSUs, including with respect to vesting."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-24-003531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000114036124003531/form4.xml","form_type":"4"}},{"id":1673073,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-23T20:37:41.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72206,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these restricted stock units (\"RSUs\") that was outstanding as of immediately prior to the Effective Time was cancelled and the Reporting Person was entitled to receive the Merger Consideration in respect of each such RSU."}],"balance_after":17021,"source":{"system":"sec-edgar","filing":"0001140361-24-003531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000114036124003531/form4.xml","form_type":"4"}},{"id":1673072,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-23T20:37:41.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27801,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 8, 2023, among the Issuer, Bristol-Myers Squibb Company (\"BMS\"), and Vineyard Merger Sub Inc., a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of January 23, 2024 (such date and time of such Merger, the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of BMS."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each issued and outstanding share of common stock of the Issuer (\"Company Common Stock\") reported in this Form 4 was converted into the right to receive (A) $58.00 per share in cash (the \"Closing Consideration\") and (B) one contingent value right (a \"CVR\"), which represents the right to receive the Milestone Payment (as such term is defined in the CVR Agreement, which is itself defined in the Merger Agreement) (the consideration contemplated by (A) and (B), together, the \"Merger Consideration\"), without interest and subject to any withholding taxes."}],"balance_after":89227,"source":{"system":"sec-edgar","filing":"0001140361-24-003531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000114036124003531/form4.xml","form_type":"4"}},{"id":1676459,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-18T16:45:36.000Z","date":"2024-01-16","kind":"sale","planned":false,"acquired":false,"shares":631,"price":59.02,"value":37241.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with\nthe vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021."}],"balance_after":117028,"source":{"system":"sec-edgar","filing":"0001628280-24-001696","document":"wk-form4_1705614324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000162828024001696/wk-form4_1705614324.xml","form_type":"4"}},{"id":1676458,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-18T16:45:36.000Z","date":"2024-01-16","kind":"sale","planned":false,"acquired":false,"shares":966,"price":59.02,"value":57013.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with\nthe vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022."}],"balance_after":117659,"source":{"system":"sec-edgar","filing":"0001628280-24-001696","document":"wk-form4_1705614324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000162828024001696/wk-form4_1705614324.xml","form_type":"4"}},{"id":1682801,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-09T17:54:37.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":2090,"price":58.92,"value":123142.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020."}],"balance_after":118625,"source":{"system":"sec-edgar","filing":"0001628280-24-000977","document":"wk-form4_1704840865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000162828024000977/wk-form4_1704840865.xml","form_type":"4"}},{"id":1692772,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T18:13:04.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":17021,"price":58.75,"value":999983.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested."}],"balance_after":120715,"source":{"system":"sec-edgar","filing":"0001628280-24-000290","document":"wk-form4_1704323573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000162828024000290/wk-form4_1704323573.xml","form_type":"4"}},{"id":1707633,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-18T16:30:30.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":15021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 14, 2023. This option shall vest over three years in twelve equal quarterly installments on each quarterly anniversary of October 31, 2023, subject to the reporting person's continued service with the Issuer."}],"balance_after":15021,"derivative":{"exercise_price":3.61,"expiration_date":"2033-12-13","underlying":"Ordinary Shares","underlying_shares":15021},"source":{"system":"sec-edgar","filing":"0000950170-23-071117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017023071117/ownership.xml","form_type":"4"}},{"id":1711018,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T17:05:02.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":2220,"price":56.67,"value":125807.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021."}],"balance_after":103694,"source":{"system":"sec-edgar","filing":"0001628280-23-041610","document":"wk-form4_1702591488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000162828023041610/wk-form4_1702591488.xml","form_type":"4"}},{"id":1810903,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-10T16:23:46.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":22297,"price":37,"value":824989.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the one year anniversary of the grant date."}],"balance_after":105914,"source":{"system":"sec-edgar","filing":"0001628280-23-028881","document":"wk-form4_1691699017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000162828023028881/wk-form4_1691699017.xml","form_type":"4"}},{"id":2047529,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-24T16:00:39.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":45456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":45456,"derivative":{"exercise_price":45.66,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":45456},"source":{"system":"sec-edgar","filing":"0001214659-23-001045","document":"marketforms-58269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465923001045/marketforms-58269.xml","form_type":"4"}},{"id":2047528,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-24T16:00:39.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":36394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 25% annually on the anniversary of the grant date until fully vested."}],"balance_after":83617,"source":{"system":"sec-edgar","filing":"0001214659-23-001045","document":"marketforms-58269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465923001045/marketforms-58269.xml","form_type":"4"}},{"id":2050952,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-19T09:45:09.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":619,"price":42.3814,"value":26234.0866,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021."}],"balance_after":47223,"source":{"system":"sec-edgar","filing":"0001214659-23-000808","document":"marketforms-58206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465923000808/marketforms-58206.xml","form_type":"4"}},{"id":2050951,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-19T09:45:09.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":947,"price":42.3779,"value":40131.8713,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022."}],"balance_after":47842,"source":{"system":"sec-edgar","filing":"0001214659-23-000808","document":"marketforms-58206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465923000808/marketforms-58206.xml","form_type":"4"}},{"id":2057569,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-10T17:00:26.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":2088,"price":45.37,"value":94732.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020."}],"balance_after":48789,"source":{"system":"sec-edgar","filing":"0001214659-23-000466","document":"marketforms-58145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465923000466/marketforms-58145.xml","form_type":"4"}},{"id":2078840,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-12-21T21:20:41.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":3248,"price":40.4143,"value":131265.6464,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1."}],"balance_after":50877,"source":{"system":"sec-edgar","filing":"0001214659-22-015199","document":"marketforms-57924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465922015199/marketforms-57924.xml","form_type":"4"}},{"id":2078839,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-12-21T21:20:41.000Z","date":"2022-12-19","kind":"grant","acquired":true,"shares":19149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Performance Stock Units (\"PSUs\"). 1/3 of the PSUs have vested on December 19, 2022 (one week after the \"Achievement Date\" of December 12, 2022). 1/3 of the remaining shares will vest on the one year anniversary of the Achievement Date and the remaining 1/3 will vest on the two year anniversary of the Achievement Date, subject to Mr. Hickey's continuous service."}],"balance_after":54125,"source":{"system":"sec-edgar","filing":"0001214659-22-015199","document":"marketforms-57924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465922015199/marketforms-57924.xml","form_type":"4"}},{"id":2236133,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:00:32.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest in twelve equal monthly installments following the date of grant or, if earlier, upon the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":24000,"derivative":{"exercise_price":2.01,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-22-036147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000120919122036147/doc4.xml","form_type":"4"}},{"id":2433857,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-18T20:32:37.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":17821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":17821,"derivative":{"exercise_price":124.31,"expiration_date":"2032-01-13","underlying":"Common Stock","underlying_shares":17821},"source":{"system":"sec-edgar","filing":"0001214659-22-000855","document":"marketforms-55092.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465922000855/marketforms-55092.xml","form_type":"4"}},{"id":2433856,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-18T20:32:37.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":627,"price":120.4828,"value":75542.7156,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $120.2091 to $120.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":34976,"source":{"system":"sec-edgar","filing":"0001214659-22-000855","document":"marketforms-55092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465922000855/marketforms-55092.xml","form_type":"4"}},{"id":2433855,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-18T20:32:37.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":10755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 25% annually on the anniversary of the grant date until fully vested."}],"balance_after":35603,"source":{"system":"sec-edgar","filing":"0001214659-22-000855","document":"marketforms-55092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465922000855/marketforms-55092.xml","form_type":"4"}},{"id":2440174,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-07T20:27:00.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":1964,"price":135.9389,"value":266983.9996,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $135.6428 to $135.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":24848,"source":{"system":"sec-edgar","filing":"0001214659-22-000471","document":"marketforms-55028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465922000471/marketforms-55028.xml","form_type":"4"}},{"id":2444225,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T18:00:16.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in 36 equal monthly installments following December 10, 2021, so long as the grantee remains a director or other service provider of the Company on such dates."}],"balance_after":24000,"derivative":{"exercise_price":5.08,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-22-001906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000120919122001906/doc4.xml","form_type":"4"}},{"id":2776369,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2021-03-22T16:42:22.000Z","date":"2021-03-19","kind":"exercise","acquired":false,"shares":2369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":30116,"derivative":{"exercise_price":114.33,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":2369},"source":{"system":"sec-edgar","filing":"0001214659-21-003327","document":"marketforms-52052.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921003327/marketforms-52052.xml","form_type":"4"}},{"id":2776368,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-03-22T16:42:22.000Z","date":"2021-03-19","kind":"sale","acquired":false,"shares":431,"price":177.7056,"value":76591.1136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $177.29 to $178.00.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26812,"source":{"system":"sec-edgar","filing":"0001214659-21-003327","document":"marketforms-52052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921003327/marketforms-52052.xml","form_type":"4"}},{"id":2776367,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-03-22T16:42:22.000Z","date":"2021-03-19","kind":"sale","acquired":false,"shares":1350,"price":176.4229,"value":238170.915,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $176.048 to $177.02.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27243,"source":{"system":"sec-edgar","filing":"0001214659-21-003327","document":"marketforms-52052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921003327/marketforms-52052.xml","form_type":"4"}},{"id":2776366,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-03-22T16:42:22.000Z","date":"2021-03-19","kind":"sale","acquired":false,"shares":588,"price":175.5367,"value":103215.5796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $175.04 to $176.00.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28593,"source":{"system":"sec-edgar","filing":"0001214659-21-003327","document":"marketforms-52052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921003327/marketforms-52052.xml","form_type":"4"}},{"id":2776365,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-03-22T16:42:22.000Z","date":"2021-03-19","kind":"exercise","acquired":true,"shares":2369,"price":114.33,"value":270847.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020"}],"balance_after":29181,"source":{"system":"sec-edgar","filing":"0001214659-21-003327","document":"marketforms-52052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921003327/marketforms-52052.xml","form_type":"4"}},{"id":2902525,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-20T18:18:25.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":10979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":10979,"derivative":{"exercise_price":214.47,"expiration_date":"2031-01-14","underlying":"Common Stock","underlying_shares":10979},"source":{"system":"sec-edgar","filing":"0001214659-21-000684","document":"marketforms-50974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921000684/marketforms-50974.xml","form_type":"4"}},{"id":2902524,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-20T18:18:25.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":7023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 25% annually on the anniversary of the grant date until fully vested."}],"balance_after":26812,"source":{"system":"sec-edgar","filing":"0001214659-21-000684","document":"marketforms-50974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921000684/marketforms-50974.xml","form_type":"4"}},{"id":2912368,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-08T19:46:04.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":2069,"price":216.33,"value":447586.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020."}],"balance_after":19789,"source":{"system":"sec-edgar","filing":"0001214659-21-000338","document":"marketforms-50911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921000338/marketforms-50911.xml","form_type":"4"}},{"id":2912367,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-08T19:46:04.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":9,"price":215.307,"value":1937.763,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020."}],"balance_after":21858,"source":{"system":"sec-edgar","filing":"0001214659-21-000338","document":"marketforms-50911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465921000338/marketforms-50911.xml","form_type":"4"}},{"id":3315356,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-08T21:06:47.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":32485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested."}],"balance_after":32485,"derivative":{"exercise_price":114.33,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":32485},"source":{"system":"sec-edgar","filing":"0001214659-20-000226","document":"marketforms-47393.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465920000226/marketforms-47393.xml","form_type":"4"}},{"id":3315355,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-01-08T21:06:47.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":21867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 25% annually on the anniversary of the grant date until fully vested."}],"balance_after":21867,"source":{"system":"sec-edgar","filing":"0001214659-20-000226","document":"marketforms-47393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753055/000121465920000226/marketforms-47393.xml","form_type":"4"}},{"id":3403283,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Commerical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-10-01T23:10:12.000Z","date":"2019-10-01","kind":"exercise","acquired":false,"shares":20216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the Issuer."}],"balance_after":60647,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20216},"source":{"system":"sec-edgar","filing":"0001104659-19-052329","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000110465919052329/a4.xml","form_type":"4"}},{"id":3403282,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2019-10-01T23:10:12.000Z","date":"2019-10-01","kind":"tax_withholding","acquired":false,"shares":6990,"price":15.46,"value":108065.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 6,990 shares represents the shares that were withheld by the Issuer as payment for minimum statutory tax withholding requirements."}],"balance_after":13226,"source":{"system":"sec-edgar","filing":"0001104659-19-052329","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000110465919052329/a4.xml","form_type":"4"}},{"id":3403281,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2019-10-01T23:10:12.000Z","date":"2019-10-01","kind":"exercise","acquired":true,"shares":20216,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20216,"source":{"system":"sec-edgar","filing":"0001104659-19-052329","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000110465919052329/a4.xml","form_type":"4"}},{"id":3657068,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-14T23:29:42.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":37538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on such date and one-fourth on each anniversary thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests one-fourth on such date and one-fourth on each anniversary thereafter."}],"balance_after":37538,"derivative":{"exercise_price":0,"exercise_date":"2020-02-12","underlying":"Common Stock","underlying_shares":37538},"source":{"system":"sec-edgar","filing":"0001179110-19-001935","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019001935/edgar.xml","form_type":"4"}},{"id":3657067,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Commercial Officer"}}],"security":"Options to purchase common stock","published_at":"2019-02-14T23:29:42.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":71602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and 1/48 monthly thereafter."}],"balance_after":71602,"derivative":{"exercise_price":16.65,"exercise_date":"2020-02-12","expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":71602},"source":{"system":"sec-edgar","filing":"0001179110-19-001935","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019001935/edgar.xml","form_type":"4"}},{"id":3799059,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-10-03T20:10:09.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":80863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on such date and one-fourth on each anniversary thereafter."}],"balance_after":80863,"derivative":{"exercise_price":0,"exercise_date":"2019-10-01","expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":80863},"source":{"system":"sec-edgar","filing":"0001179110-18-012004","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018012004/edgar.xml","form_type":"4"}},{"id":3799058,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":14836,"kind":"person","name":"Hickey Benjamin","position":1,"cik":"0001753055","reported_name":"Hickey Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Commercial Officer"}}],"security":"Options to purchase common stock","published_at":"2018-10-03T20:10:09.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":149516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and 1/48 monthly thereafter."}],"balance_after":149516,"derivative":{"exercise_price":18.55,"exercise_date":"2019-10-01","expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":149516},"source":{"system":"sec-edgar","filing":"0001179110-18-012004","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018012004/edgar.xml","form_type":"4"}}]}